Vnitr Lek 2020, 66(8):e24-e27 | DOI: 10.36290/vnl.2020.154

Male hypogonadism associated with obesity

Luboslav Stárka, Michaela Dušková, Martin Hill
Endokrinologický ústav Praha

Male hypogonadism associated with obesity by yet not fully understood mechanisms promote fat depositions and on contrary obesity induces decrease of androgen production. It is necessary to diagnose hypogonadism correctly and to treat it. The definition of hypogonadism is based on subnormal levels of circulating testosterone and on the occurrence of symptoms, which, however, are not much specific. As obesity decreases substantially the concentrations of sex hormone binding globulin SHBG it is recommended in these men to check not only the level of total testosterone but also the concentration of free testosterone or the value of the index of free androgens. Proven hypogonadism in obese men should be treated as well as by testosterone substitution as the body mass reduction. The most effective treatment in this respect is considered bariatric surgery.

Keywords: male hypogonadism, obesity, SHBG, testosterone.

Published: December 15, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stárka L, Dušková M, Hill M. Male hypogonadism associated with obesity. Vnitr Lek. 2020;66(8):e24-27. doi: 10.36290/vnl.2020.154.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018; 103: 1715-1744. Go to original source... Go to PubMed...
    2. Čáp J. Androgenní deficit a diabetes. Vnitř Lék 2012; 58: 228-231. Go to PubMed...
    3. Dhindsa S, Ghanim H, Batra M, et al. Hypogonadotropic hypogonadism in men with diabesity. Diabetes Care 2018; 41: 1516-1525. Go to original source... Go to PubMed...
    4. Dohle GR, Arvec S, Bettocchi C, Jones TH, et al. Male hypogonadism. Guidelines EAU 2017. http//uroweb.org/guideline/m ale‑hypogonadism/.
    5. Escobar‑Morreale HF, Santacruz E, Luque‑Ramírez M, et al. Prevalence of 'obesity‑associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta‑analysis. Hum Reprod Update 2017; 23: 390-408. Go to original source... Go to PubMed...
    6. Fryšák Z, Karásek D, Halenka M. Hypogonadismus mužů - příčiny, diagnostika, léčba. Urol pro praxi 2010; 11: 75-77.
    7. Fui MNT, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanism, morbidity and management. Asiian Jj Adrology 2014; 16: 223-231. Go to original source... Go to PubMed...
    8. Grossmann M. Hypogonadism and male obesity. Focus on unresolved questions. Clin Endocrinol (Oxf) 2018; 89: 11-21. Go to original source... Go to PubMed...
    9. Hána V, Kosák M, Hána jr. V. Hypogonadismus u mužů a jeho léčba. Čas Lék Čes 2017; 156: 258-265.
    10. Hanuš M., Matoušková M, Hill M, et al. Hormonal homeostasis in a group of 216 ageing Czech males and correlation with responses to a questionnaire of the University of St. Louis. Aging Male 2006; 9: 103-110. Go to original source... Go to PubMed...
    11. Kahn BE, Brannigan RE. Obesity and male infertility. Curr Opin Urol 2017; 27: 441-445. Go to original source... Go to PubMed...
    12. Kubíček V. Racionální substituční terapie androgeny pro muže. Andrologie 2000, 1: 1-9.
    13. Molina‑Vega M, Muñoz‑Garach A, Damas‑Fuentes M, et al. Secondary male hypogonadism: a prevalent but overlooked comorbidity of obesity. Asian J Androl 2018; 20: 531-538. Go to original source... Go to PubMed...
    14. Mushannen T, Cortez P, Stanford FC, et al. Obesity and hypogonadism - A narrative review highlighting the need for high‑quality data in adolescents. Children (Basel) 2019; 6: E63. Go to original source... Go to PubMed...
    15. Noe S. Adipositas‑assoziirter Hypogonadism. Endocrinol Info 2019; Sonderheft: 24-27.
    16. Pivonello R, Menafra D, Riccio E, et al. Metabolic disorders and male hypogonadotropic Hypogonadism. Front. Endocrinol 2019; https://doi.org/10.3389/fendo.2019.00345. Go to original source... Go to PubMed...
    17. Poršová‑Dutoit I. Mužský hypogonadism. Nedostatečná funkce mužských pohlavních žláz. Praha: Maxdorf 2005, 183 s.
    18. Pospisilova H, Duskova M, Hill M, et al. Changes of steroidogenesis subject to weight growth. ECE 2013 Copenhagen, http://www.endocrine‑abstracts.org/ea/0032/ea0032p976.htm Go to original source...
    19. Ring J, Welliver C, Parenteau M, et al. The utility of sex hormone‑binding globulin in hypogonadism and infertile males. J Urol 2017; 197: 1326-1331. Go to original source... Go to PubMed...
    20. Stárka L, Jirásek JE. Hypogonadismus mužský. In: Stárka L Endokrinologie. Lékařské repetitorium. Praha: Triton 2010, 98-124.
    21. Stárka L. Hormonální substituční terapie u stárnoucích mužů. Urologie pro praxi | 2009; 10(5)
    22. Stárka L. Substituční léčba testosteronem u mužů v andropauze. Prakt Lék 2007; 87: 184-188.
    23. Stárka L. Mužský hypogonadismus a civilizační onemocnění. Čas Lék Čes 2012; 151: 69-72.
    24. Šrámková T. Bez testosteronu to nepůjde. In: Kvapil M. Diabetologie 2018. Praha: Triton 2018; 321-333.

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.